- AirSculpt posted a net loss of USD 12 million for fiscal 2025, widening from the prior year.
- Revenue fell 15.8% to USD 150 million on lower case volume, partly offset by higher pricing.
- Adjusted EBITDA slid to USD 15 million, bringing adjusted EBITDA margin down to 9.9%.
- Cases performed dropped to 11,852, while revenue per case edged down 0.3% to USD 12,809.
- Management said it is targeting a return to growth by optimizing marketing, improving sales execution, expanding financing, and pushing new product innovation in skin tightening.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Airsculpt Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001870940-26-000011), on March 31, 2026, and is solely responsible for the information contained therein.
Comments